These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature. Myzienski AE; Lutz MF; Smythe MA Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615 [TBL] [Abstract][Full Text] [Related]
8. New method to predict patients' intravenous heparin dose requirements. Reilly BM; Raschke RA J Gen Intern Med; 1996 Mar; 11(3):168-73. PubMed ID: 8667094 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients. Hosch LM; Breedlove EY; Scono LE; Knoderer CA Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Therapy Strategy for Cancer-Associated Ischemic Stroke: A Case Series of 26 Patients. Naito H; Nezu T; Hosomi N; Aoki S; Ueno H; Ochi K; Maruyama H J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e206-e211. PubMed ID: 29779882 [TBL] [Abstract][Full Text] [Related]
15. Heparin therapy: current regimens and principles of monitoring. Berry BR; Nantel S Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639 [TBL] [Abstract][Full Text] [Related]
16. Activated partial thromboplastin times from venipuncture versus central venous catheter specimens in adults receiving continuous heparin infusions. Dailey MS; Berger B; Dabu F Crit Care Nurse; 2014 Oct; 34(5):27-42. PubMed ID: 25274762 [TBL] [Abstract][Full Text] [Related]
17. Unfractionated heparin dosing for therapeutic anticoagulation in critically ill obese adults. Hohner EM; Kruer RM; Gilmore VT; Streiff M; Gibbs H J Crit Care; 2015 Apr; 30(2):395-9. PubMed ID: 25534987 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis. Hirsh J Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124 [TBL] [Abstract][Full Text] [Related]
20. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients. Low CL; Bailie G; Morgan S; Eisele G Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]